CORC

浏览/检索结果: 共11条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan
收藏  |  浏览/下载:10/0  |  提交时间:2022/12/22
COST-EFFECTIVENESS STUDY OF ALECTINIB VERSUS CRIZOTINIB IN FIRST-LINE TREATMENT FOR ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NSCLC IN CHINA 会议论文
作者:  Zhang, L.;  Dong, X.;  Zhao, J.;  Hu, J.;  Liu, C.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:  Yu, Hui;  Sun, Si;  Hu, Xingjiang;  Xia, Jinjing;  Wang, Jialei
收藏  |  浏览/下载:25/0  |  提交时间:2019/12/05
Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant 期刊论文
2018, 卷号: 9, 期号: 10, 页码: 1327-1332
作者:  Song, Peng;  Zhang, Jingcheng;  Shang, Congcong;  Zhang, Li
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 8, 页码: 1541-1550
作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye
收藏  |  浏览/下载:121/0  |  提交时间:2019/01/08
Drug resistance in ALK-positiveNon-small cell lungcancer patients 期刊论文
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 卷号: 64
作者:  Qian, Mengjia;  Zhu, Bijun;  Wang, Xiangdong;  Liebman, Michael
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 卷号: 26, 期号: 22, 页码: 5399-5402
作者:  Han, Mei;  Wang, Chengyan;  Ji, Yinchun;  Song, Zilan;  Xing, Li
收藏  |  浏览/下载:66/0  |  提交时间:2019/01/08
An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 118, 页码: 244-249
作者:  Song, Zilan;  Xia, Zongjun;  Ji, Yinchun;  Xing, Li;  Gao, Yinglei
收藏  |  浏览/下载:70/0  |  提交时间:2019/01/08
Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non-Small Cell Lung Cancer Cells 期刊论文
NEOPLASIA, 2016, 卷号: 18, 期号: [db:dc_citation_issue], 页码: 162-171
作者:  Dong, Xuyuan;  Fernandez-Salas, Ester;  Li, Enxiao;  Wang, Shaomeng
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/02
Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure-activity relationship study 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 卷号: 105, 页码: 39-56
作者:  Jiang, Xiaolong;  Zhou, Ji;  Ai, Jing;  Song, Zilan;  Peng, Xia
收藏  |  浏览/下载:61/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace